Ardent Health Partners (NYSE:ARDT) Releases FY24 Earnings Guidance

Ardent Health Partners (NYSE:ARDT) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share guidance of $1.23-1.37 for the period, compared to the consensus earnings per share estimate of $1.21. The company issued revenue guidance of $5.75-5.90 billion, compared to the consensus revenue estimate of $5.84 billion.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on ARDT. Truist Financial began coverage on shares of Ardent Health Partners in a research report on Monday. They set a buy rating and a $21.00 price objective for the company. Stephens started coverage on Ardent Health Partners in a research note on Monday. They issued an overweight rating and a $24.00 price target on the stock. Royal Bank of Canada assumed coverage on Ardent Health Partners in a research note on Monday. They set an outperform rating and a $23.00 price target on the stock. Morgan Stanley started coverage on Ardent Health Partners in a report on Monday. They set an overweight rating and a $27.00 price objective for the company. Finally, Mizuho assumed coverage on shares of Ardent Health Partners in a research report on Monday. They set an outperform rating and a $20.00 target price on the stock. One research analyst has rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of Buy and a consensus target price of $21.70.

Ardent Health Partners Price Performance

Shares of NYSE ARDT traded down $0.01 during midday trading on Wednesday, reaching $16.00. The stock had a trading volume of 204,359 shares, compared to its average volume of 333,677. Ardent Health Partners has a 12-month low of $15.00 and a 12-month high of $18.16.

About Ardent Health Partners

We are the fourth largest privately held, for-profit operator of hospitals and a leading provider of healthcare services in the United States(1). We currently operate in eight growing mid-sized urban markets across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. We deliver care through a system of 30 acute care hospitals, more than 200 sites of care, and over 1,700 providers that are either employed by or affiliated with us(2), as of March 31, 2024.